A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease

Although [(18)F]fluoro-L-dopa [FDOPA] positron emission tomography (PET) has been used as a surrogate outcome measure in Parkinson's disease therapeutic trials, this biomarker has not been proven to reflect clinical status longitudinally. We completed a retrospective analysis of relationships b...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gallagher, Catherine L., Johnson, Sterling C., Bendlin, Barbara B., Chung, Moo K., Holden, James E., Oakes, Terrence R., Brooks, Benjamin R., Konopacki, Richard A., Dogan, Selami, Abbs, James H., Xu, Guofan, Nickles, Robert J., Pyzalski, Robert W., DeJesus, Onofre T., Brown, W. Douglas
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3150388/
https://ncbi.nlm.nih.gov/pubmed/21556744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11682-011-9124-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires